The largest database of trusted experimental protocols

3 protocols using stemfit

1

Optimizing hESC and iPSC Culture Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
All hESC and iPSC lines (H1, H9, HUES53, LiPSC-GR1.1) were adapted to and maintained for at least 3 passages in each media tested (E8, StemFlex, (Thermo Fisher Scientific), mTeSR (STEMCELL Technologies), MEF conditioned media (MEF-CM; R&D Systems) or StemFit (AMSBIO). 384-well white flat bottom plates (Corning) were coated with VN, LN521, or Matrigel at 37 °C for 1 h. Coating media was removed and each well immediately received 30 μl of the appropriate media supplemented with DMSO (2X), CEPT (2X), Y-27632 (20 μM), CloneR (2X; STEMCELLTechnologies), RevitaCell (2X; Thermo Fisher Scientific) or SMC3/4 (2X; BioVision). Once 384-well plates were ready, cells were dissociated with Accutase, re-suspended in the appropriate medium without supplements and dispensed into the 384-well plates at 2000 cells/well (30 μl per well, resulting in a final assay volume of 60 μl in each well and a final concentration of 1X for each supplement). After 24 h, 30 μl CTG was dispensed into each well and luminescence signals were read using the ViewLux μHTS microplate imager (Perkin-Elmer). All plates were prepared in six replicates to compensate for cell dispensing variation (see Supplementary Fig. 3).
+ Open protocol
+ Expand
2

Optimizing hESC and iPSC Culture Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
All hESC and iPSC lines (H1, H9, HUES53, LiPSC-GR1.1) were adapted to and maintained for at least 3 passages in each media tested (E8, StemFlex, (Thermo Fisher Scientific), mTeSR (STEMCELL Technologies), MEF conditioned media (MEF-CM; R&D Systems) or StemFit (AMSBIO). 384-well white flat bottom plates (Corning) were coated with VN, LN521, or Matrigel at 37 °C for 1 h. Coating media was removed and each well immediately received 30 μl of the appropriate media supplemented with DMSO (2X), CEPT (2X), Y-27632 (20 μM), CloneR (2X; STEMCELLTechnologies), RevitaCell (2X; Thermo Fisher Scientific) or SMC3/4 (2X; BioVision). Once 384-well plates were ready, cells were dissociated with Accutase, re-suspended in the appropriate medium without supplements and dispensed into the 384-well plates at 2000 cells/well (30 μl per well, resulting in a final assay volume of 60 μl in each well and a final concentration of 1X for each supplement). After 24 h, 30 μl CTG was dispensed into each well and luminescence signals were read using the ViewLux μHTS microplate imager (Perkin-Elmer). All plates were prepared in six replicates to compensate for cell dispensing variation (see Supplementary Fig. 3).
+ Open protocol
+ Expand
3

Maintenance of human iPSC and H9 hESC lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSC line WTC11 (a kind gift from Bruce Conklin, Gladstone Institute of Cardiovascular Disease) was maintained in mTeSR1 (Stemcell Technologies) on Matrigel (Corning)-coated six-well plates (Corning) in a 37 °C incubator with 5% CO2. At 70–80% confluence, cells were dissociated with Accutase (Stemcell Technologies) and plated on Matrigel-coated six-well plates with mTeSR™1 containing 10 μM Rho kinase inhibitor, Y27632 (EMD Millipore). Y27632 was removed after the first 48 h and thereafter media was replaced with fresh mTeSR1 every day. Human H9 (purchased from Wicell) or H9-FP ubiquitously expressing miRFP703 fused to histone H2B (a kind gift from Dr. Andrew McMahon, University of Southern California) were maintained in StemFit (amsbio) with 100 ng/ml human FGF2 (R&D) on Geltrex (Thermo Fisher Scientific)-coated six-well plates. At 70–80% confluence, cells were dissociated with Accutase and plated on Geltrex-coated six-well plates with StemFit containing 100 ng/ml human FGF2 and 10 μM Y27632. After 48 h of culture, medium was replaced with fresh StemFit containing 50 ng/ml human FGF2. After the next 48 h, medium was replaced with fresh StemFit containing 25 ng/ml human FGF2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!